clinical research to see the effect of herbal drug in the treatment of bacterial vaginosis

Efficacy of Habbe Mufeed Sailan in Bacterial vaginosis: A Single Blind Randomized Standard Control Study.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010172

Enrollment

Registered

2017-10-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- bacterial vaginosis

Interventions

Intervention1: habbe mufeed sailan: Ingredients: Post darakhte neem (bark of Azadirachta indica) Mazoo (Quercus infectoria) Kath safaid (Acacia catechu) dosage: Habbe Mufeed Sailan (each tab of 2g) tw

Eligibility

Inclusion criteria

Inclusion criteria: Presence of bacterial vaginosis diagnosed by Amselâ??s criteria. Amselâ??s criteria (if 3 of the 4 criteria are positive, the patient has bacterial vaginosis)16 Homogenous white discharge • pH of the vagina being > 4.5, • The presence of clue cells • Positive whiff test

Exclusion criteria

Exclusion criteria: • Pregnant and lactating women. • Recent h/o topical or systemic use of antibiotics (within 1 month) • Patients using OCPs and IUCDs • Organic pelvic pathology, Sexually transmitted diseases and systemic illness.

Design outcomes

Primary

Measure	Time frame
â?¢ Amselâ??s criteriaTimepoint: 3 weeks	—

Secondary

Measure	Time frame
â?¢ Improvement in HR Quality of life assessed by SF-36 questionnaire.Timepoint: 3 weeks	—

Countries

India

Contacts

Public ContactMariyam Roqaiya

Luqman Unani Medical College Hospital and Research Centre

smart4shanwaz@yahoo.com9739370856

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026